
WeightWatchers files for bankruptcy after rise of Ozempic and Mounjaro
WeightWatchers has filed for bankruptcy in the US amid struggles with debt and competition from new drugs such as Ozempic and Mounjaro. The legal proceedings will result in $1.15bn (£860mn) of the diet company's debt being written off, while it …